SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales slipped to Rs. 44660.70 millions for the June 2023 quarter as against Rs. 49328.80 millions during the year-ago period.The Net Profit of the company slipped to Rs. 3806.40 millions from Rs. 10118.00 millions, a decline of -62.38% on QoQ basis.A decline of 11123.00 millions was observed in the OP in the quarter ended June 2023 from 14986.50 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 44660.70 49328.80 -9.46 44660.70 49328.80 -9.46 208121.40 155859.80 33.53
Other Income 1635.40 1762.10 -7.19 1635.40 1762.10 -7.19 3292.90 11968.80 -72.49
PBIDT 11123.00 14986.50 -25.78 11123.00 14986.50 -25.78 67518.90 38654.40 74.67
Interest 1579.40 870.70 81.39 1579.40 870.70 81.39 4721.80 3881.00 21.66
PBDT 8051.50 14115.80 -42.96 8051.50 14115.80 -42.96 33419.20 16568.10 101.71
Depreciation 4152.70 3745.00 10.89 4152.70 3745.00 10.89 16008.70 13499.50 18.59
PBT 3898.80 10370.80 -62.41 3898.80 10370.80 -62.41 17410.50 3068.60 467.38
TAX 92.40 252.80 -63.45 92.40 252.80 -63.45 503.30 4068.50 -87.63
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 3806.40 10118.00 -62.38 3806.40 10118.00 -62.38 16907.20 -999.90 -1790.89
Equity 2399.30 2399.30 0.00 2399.30 2399.30 0.00 2399.30 2399.30 0.00
PBIDTM(%) 24.91 30.38 -18.02 24.91 30.38 -18.02 32.44 24.80 30.81

Sun Pharma Inds. Share Price

1675.20 -17.95 (-1.06%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×